PTFE back pressure regulator used in continuous pharmaceutical research at MIT -
  • fr
  • de
  • ja
  • es
  • ar
  • ar
  • ar

PTFE back pressure regulator used in continuous pharmaceutical research at MIT

Membrane Separation

  • PTFE back pressure regulator used in continuous pharmaceutical research and membrane separation

The Novartis-MIT Center for Continuous Manufacturing conducts research into the emerging field of continuous manufacturing of pharmaceutical compounds. Dr. Stephen Born, working with Dr. Bernard Trout Group at the Massachusetts Institute of Technology has conducted extensive flow chemistry research using micro-reactors and membrane separation of organics and aqueous phases.

This research has been published in the paper End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation. In this research, 12 parallel 1 μm Pall Zelfuor membranes were used to separate micro-reactor products into aqueous and organic phases. As documented in the supporting information, a single Equilibar 1/4″ PTFE back pressure regulator was used to control the merged aqueous membrane outlet streams at a differential pressure 700 Pascals higher than the organic phase.

Equilibar has both 100% PTFE and 100% Hastelloy back pressure regulators available to meet the demanding requirements of continuous pharmaceutical research. These regulators can be used for both flow control and pressure control applications.

Categories
Equilibar News
Greg Rachkovsky

Team Member Profile: Greg Rachkovsky, Inventory Specialist

The Equilibar team is happy to introduce Greg Rachkovsky, inventory specialist for shipping and receiving, who joined us in the spring of this year. In addition to keeping up with thousands of parts and materials so that our production team always has what they need to fulfill orders, Greg enjoys cross training and helping with Read More

Read More